Should olaparib maintenance therapy be recommended in patients with BRCA-positive, advanced ovarian cancer after first line platinum-based chemotherapy?

Should this be the new standard of care based on the results from the recently published SOLO-1 trial?

Answer from: Medical Oncologist at Community Practice

While the results of the SOLO-1 trial are initially impressive, we need to wait for the survival data and the results of the other 2 European trials (Paola-1 and ENGOT). Definitively a field of research to keep an eye on. Today, probably premature. On a case by case basis, might be acceptable, but n...

Comments

at Tulane University School of Medicine
I will respectfully disagree with my good friend, ...

Please select the option that best describes you:

Should olaparib maintenance therapy be recommended in patients with BRCA-positive, advanced ovarian cancer after first line platinum-based chemotherapy?

Related Questions